ARCHIVES

Review Planned Of 54 Deaths In First 60 Days On Studies.

This article is from The Cancer Letter archive.

Vol. 27 No. 25 | June 22, 2001

Download PDF Visit The Full Archive

Related Articles

MacFarlane, Frelick to Speak At Seminar

July 22, 1983

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Research Funding: 30 Groups Sign Letter For Double NCI Budget

January 23, 1998

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990

Orders Still Accepted For 20th Anniversary Special Publication

July 19, 1991